The goal of this clinical trial is to evaluate whether telemonitoring, added to the usual process of adaptation to home mechanical ventilation (HMV), achieves a more efficient correction of hypoventilation (reduction of hypercapnia).
Chronic hypercapnic respiratory failure with indication for home mechanical ventilation.
Patients who require ventilation with spontaneous-timed mode.
Signing of informed consent.
Patient already treated with mechanical ventilation or home CPAP.
Patient requiring mechanical ventilation as life support.
Pregnancy.
Cognitive impairment that makes it impossible to understand the informed consent for the study.
Parallel
Telemonitoring
Other interventionA networked platform that enables the telemonitoring of both compliance data and the patient's ventilatory pattern, allowing the assessment of flow/pressure curves as well as leaks or events related to the upper airway.
Measurement of pCO2 by arterial blood gas
The partial pressure of carbon dioxide (PCO2) is the measure of carbon dioxide within arterial or venous blood. The moment (day) in which normal pCO2 is detected (pCO2 \< 45 mmHg) will be determined as the success of the therapy.
Adherence
Compare treatment adherence with Home Mechanical Ventilation (HMV) between monitoring with and without telemonitoring.
Unforeseen visits
Compare the number of unforeseen visits generated with both systems.
Hospital admissions
Compare the number of hospital admissions due to acute exacerbation of chronic respiratory failure with both adaptation systems.
Click on the lead sponsor to view all of their trials.
Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau
Lead sponsor
Societat Catalana de Pneumologia (SOCAP)
Collaborator
Sociedad Española de Neumología y Cirugía Torácica
Collaborator
